Clinical Trial Update: Pharmacokinetics of BF2.649 in Renal Impairment [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating BF2.649 in individuals with renal impairment to assess how reduced kidney function affects drug exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• BF2.649 (BF2.649)

Snippet

Sponsor: Bioprojet | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED